Treatment can lead to a long dry spell.
Starr
Cynthia H
CH
D001521:Behavior Therapy; D001559:Benzhydryl Compounds / Q000008:administration & dosage; D003408:Cresols / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000008:administration & dosage; D018727:Muscarinic Antagonists / Q000008:administration & dosage; D010276:Parasympatholytics / Q000008:administration & dosage; D010665:Phenylpropanolamine; D026741:Physical Therapy Modalities; D000068737:Tolterodine Tartrate; D014481:United States; D014549:Urinary Incontinence / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*
D001559:Benzhydryl Compounds; D003408:Cresols; D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D010276:Parasympatholytics; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate; C005419:oxybutynin